BackgroundsGlucagon-like peptide-1 receptor agonist (GLP-1 RA) is probably one of more effective antidiabetic agents in treatment of type 2 diabetes mellitus (T2D). However, the heterogenicity in resp
This sample is part of the GutCyc Collection (www.gutcyc.org), a compendium of environmental pathway / genome databases. GutCyc was constructed from 418 human microbiome assemblies using the open-sour
